Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC
Clinical trial NCT03616886 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03616886
- Sponsor
- Jules Bordet Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-28
- Primary completion
- 2025-03-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.